COTI-2
COTI-2, an anti-cancer agent with low toxicity, is an orally available third generation activator of p53 mutant forms. COTI-2 acts both by reactivating mutant p53 and inhibiting the PI3K/AKT/mTOR pathway. COTI-2 induces apoptosis in multiple human tumor cell lines. COTI-2 exhibits antitumor activity in HNSCC through p53-dependent and -independent mechanisms. COTI-2 converts mutant p53 to wild-type conformation[1][2][3].
Product Specifications
CAS Number
1039455-84-9
UNSPSC
12352005
Hazard Statement
H302
Target
Apoptosis; MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/COTI-2.html
Concentration
10mM
Purity
99.02
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
S=C(N1CCN(C2=NC=CC=C2)CC1)N/N=C3CCCC4=C\3N=CC=C4
Molecular Formula
C19H22N6S
Molecular Weight
366.48
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Hexokinase II Antibody [F23A5]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Zebrafish SMARCE1 Rabbit Polyclonal Antibody (PE)
Glycogen Phosphorylase Isoenzyme BB (GPBB) (Biotin) discontinued
Canine Lymphokine-Activated Killer T-Cell-Originated Protein Kinase (PBK) ELISA Kit
Canine Lymphokine-Activated Killer T-Cell-Originated Protein Kinase (PBK) ELISA Kit